GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Health Discovery HDVY · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2019

Revenue

$1.5m

FY2014FY2019

Net income

$1.6m

FY2014FY2019

Free cash flow

$2.2m

FY2014FY2019

Shareholders' equity

−$470,507

FY2014FY2019

Income statement

Fiscal years

FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$1.5m$44,300$44,951$43,512$44,601$1.0m
Gross profit$1.5m$44,300$44,951$43,512$44,601$1.0m
Research and development———$27,000$40,813$99,200
Operating income$1.6m−$769,620−$859,600−$954,145−$800,648$38,448
Net income$1.6m−$795,474−$873,887−$2.1m−$587,061$176,641
Diluted earnings per share0.00-0.00-0.00-0.01-0.000.00

Balance sheet

At each fiscal year end

FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$2.3m$152,975$459,170$873,971$1.5m$1.6m
Cash and short-term investments$2.3m$67$43,543$195,625$559,186$370,015
Total liabilities$2.8m$1.1m$744,460$351,313$731,779$804,884
Debt$200,000$407,060$175,000—$206,637—
Shareholders' equity−$470,507−$993,748−$285,290$522,658$768,668$772,005
Shares outstanding389m272m408m274m269m255m

Cash flow

Fiscal years

FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations$2.2m−$275,536−$314,005−$465,957−$608,605−$736,169
Free cash flow$2.2m−$275,536−$314,005−$465,957−$608,605−$736,169

Latest quarters

By quarter end

Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020Dec 2019
Revenue—————$1,000−$194−$194
Gross profit—————$1,000−$194—
Operating income−$494,000−$1.7m−$378,000−$355,000−$290,000−$773,000−$322,381−$141,547
Net income−$504,000−$1.7m−$386,000−$359,956−$300,000$1.4m−$1.5m−$150,294
Diluted earnings per share-0.00-0.00-0.00-0.00-0.000.00-0.00-0.00
Total assets$285,000$500,000$746,000$932,000$1.3m$1.7m$2.2m$2.3m
Cash and short-term investments$270,000$485,000$731,000$917,000$1.3m$1.7m$2.2m—
Debt$212,000$212,000$212,000$212,000$212,000$212,000$200,000—
Shareholders' equity−$582,000−$303,000−$7,000$375,000$734,000$1.0m−$1.8m−$470,507

Valuation history

At each fiscal year end

FY2020
Price to sales0.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return900%-90%6567%-56%286%420%567%101740%481%12%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.